$6.58 0.38 (+6.13%)
11/6/2009 4:03 PM

Elan Corp, plc (ADR) (ELN)

CAPS Rating: 4 out of 5

The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.

Recs

0
Member Avatar postbusters (80.24) Submitted: 11/11/2008 2:04:28 PM : Outperform Start Price: $6.68 ELN Score: -23.73

I've been following ELN for years and have been burned terribly, but each time the stock rises from the ashes to head for the stars. They have such a great success at innovative new treatments that I have to believe they will be back in the fight for the title again.

Report this Post 0 Comments

Featured Broker Partners